ALYMSYS vs RUBRACA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. ALYMSYS and RUBRACA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ALYMSYS	RUBRACA
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BEVACIZUMAB-MALY	RUCAPARIB CAMSYLATE
Manufacturer	Amneal	Pharmaand
Dosage forms	Injectable	Tablet
Drug class	—	—
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms	Ovarian Neoplasms

alymsys rubraca

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

BEVACIZUMAB-MALY

RUCAPARIB CAMSYLATE

Manufacturer

Amneal

Pharmaand

Dosage forms

Injectable

Tablet

Drug class

—

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms

Ovarian Neoplasms

Frequently asked questions

What is the difference between Alymsys and Rubraca?

Alymsys contains Bevacizumab-Maly, while Rubraca contains Rucaparib Camsylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.